OLIPHARM
ActiveSummary
OLIPHARM has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €143,156 and a net result of €3,720. Equity is growing by about 55% per year across the filed financial years. Its solvency ranks better than 30% of 11,207 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Articles of association
- Other provisionsOther rules from the articles that fall under none of the themes above.
- Other provision: “Responsabilite organe administration” (deed in French)
Read from the deeds: 1 provision, deed of 22-08-2022